SUPPORT

Mentice expands Coronary Product Portfolio with the introduction of Coronary Intermediate software

[fa icon="calendar'] Mar 12, 2020 10:01:13 AM / by Mentice posted in Press Release, Coronary Intermediate

[fa icon="comment"] 2 Comments

Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essentials three months earlier at the 20th International Meeting on Simulation in Healthcare (IMSH 2020).

Read More

RECENT POSTS

RSS-feed

Subscribe to Email Updates

OUR RESULTS ARE GLOBAL

Proud to be trusted by organizations worldwide

20+
years of experience pioneering interventional simulation.
140+
over 140 scientific papers reinforcing the value of simulation skills acquistition, retention and assessment.
49+
medical simulation patents across more than 30 different training procedures.
>50%
of global market share in endovascular simulation solutions.
Contact Us

Mentice AB
Phone: +46 31 339 94 00
Fax: +46 31 339 94 99
info@mentice.com

Europe, Middle East and Africa
+46 31 339 94 00 
sales_emea@mentice.com

USA
+1-877 636-8423
sales_us@mentice.com

Asia/Pacific 
+46 31 339 94 00
sales_ap@mentice.com

Latin America
+55 11 94224 0069
sales_latam@mentice.com

About Us

Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural  skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions.
Data Protection Policy  Legal Disclaimer  Terms and Conditions  Get in Touch  Copyright 2020 Mentice. All rights reserved.
[fa icon="chevron-up"]